Prevention and treatment of thromboembolic events in medical patients and new anticoagulants (Q37681486)

22 August 2017

1 reference

title

Prevention and treatment of thromboembolic events in medical patients and new anticoagulants (English)

1 reference

22 August 2017

1 reference

1 reference

S Balaratnam

1

1 reference

22 August 2017

language of work or name

1 reference

1 November 2009

1 reference

22 August 2017

1 reference

22 August 2017

volume

64

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

547-552

1 reference

Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Fatal pulmonary embolism in hospitalised patients: a necropsy review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Toward a population-based assessment of death due to pulmonary embolism in New Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

The pharmacokinetics of fondaparinux sodium in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/ACB.2009.093

21 January 2018

Identifiers

DOI

10.1179/ACB.2009.093

1 reference

22 August 2017

1 reference